Bafna Pharmaceuticals P/B Ratio
Bafna Pharmaceuticals (BAFNAPH) P/B ratio is 6.53 (High), book value per share ₹255.00 vs Healthcare average P/B of -1.0 — Very High - Significant premium, high growth expectations or speculative. Compare with BAFNAPH DCF valuation to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2020)
Valuation Signal
Sector Context
BAFNAPH P/B Ratio — Valuation Insights & Book Value Analysis
Bafna Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 6.53 (High). For live price, earnings yield and the full fundamental profile, see BAFNAPH share price.
- Stock appears overvalued with PB of 6.53, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 874.6% above historical average
- Trading at premium to sector average PB of -1.0
Bafna Pharmaceuticals P/B Ratio Historical Trend
BAFNAPH annual price-to-book ratio — 1 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Bafna Pharmaceuticals yearly highs lows for the annual high/low range and current price position.
BAFNAPH Historical P/B Ratio — Book Value Per Share & Year-End Price
Bafna Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2020 | 0.67 | ₹255.0 | ₹170.85 | ₹51 | Low |
BAFNAPH vs Healthcare Peers — P/B Ratio Comparison
Bafna Pharmaceuticals P/B 6.53 vs Healthcare average -1.0, median 0.62 — range -36.63–1.05.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -36.63 | ₹28 | Low |
| Sun Pharma Advanced Rese… | SPARC | -13.83 | ₹4,744 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.35 | ₹76 | Low |
| Parmax Pharma | PARMAX | -2.09 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |